32 /100
MEDIUM RISK
Score updated Jul 14, 2026

CNDA — Concord Acquisition Corp II Dilution Risk Tracker

Track CNDA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CNDA — Get alerts when the score changes →

As of July 14, 2026, Concord Acquisition Corp II (CNDA) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. Concord Acquisition Corp II has a market capitalization of $74.95M, 8.6K shares outstanding. Key dilution vectors include 75.0K outstanding warrants, approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
30
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
30%
📜 Warrant Exercise 60%
• Massive warrant overhang: 877% of shares outstanding
• Warrant risk score very high (90/100)
🔔 Track CNDA — Get forecast alerts →

💹 Market Data

Market Cap$74.95M
Shares Outstanding8.6K
Float8.6K
Cash$280.27M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

144.8% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track CNDA for full holder detail →

📉 Short Interest

Short Interest213
Days to Cover26.6
% of Float2.5%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for CNDA Shareholders

Concord Acquisition Corp II (CNDA) has a DilutionScore of 32/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for CNDA shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CNDA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CNDA alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CNDA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CNDA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CNDA
📊 CNDA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CNDA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.